Immunity Against Common Virus Leveraged Against Pancreatic Cancer
UC San Diego researchers have harnessed the body's immune response to a common virus to shrink pancreatic tumors, offering hope for a new cancer treatment approach.
UC San Diego researchers have harnessed the body's immune response to a common virus to shrink pancreatic tumors, offering hope for a new cancer treatment approach.
Drug resistance has accelerated in recent years with the emergence of deadly bacteria and “superbugs.” In response to this global health crisis, UC San Diego biologists have developed a new CRISPR-based technology capable of removing antibiotic-resistant elements from populations of bacteria.
At the 2026 Indigi-Con Creators Symposium, the Indigenous Futures Institute will bring artists and advocates together to celebrate Indigenous culture, storytelling and creativity, and uplifting Indigenous knowledge through community-based programming for the next generation.
Biologists have reported new insights on the influences related to metabolism and the environment surrounding CD8 T cells, the soldiers of the immune system. Their research led to intriguing insights on the role of fatty acids in chronic infections and other persistent conditions, such as tumors.
By mapping the varied states of our body's immune cells, UC San Diego researchers are working to empower the next generation of cancer immunotherapies.
A new UC San Diego study reveals that fossil fuel-based plastic pollution may be promoting toxic water conditions by removing animals that keep water at safe levels. Biologically based plastics had a much smaller impact.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
You have been successfully subscribed to the UC San Diego Today Newsletter.